In a double-blind, randomized, placebo-controlled study, intravenous iron therapy of 5-week for 40 HF patients with ID had a significant improvement not only in ferritin, TSAT, hemoglobin levels but also decreased NT-proBNP levels, compared to the control group (17). This evidence concerns the gene NPPB and hydrops fetalis.